Drugs / PnuBioVax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02572635 | Oct 2015 → Sep 2016 | pneumococcal infection | ImmunoBiology Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PnuBioVax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02572635 ↗ |
| Modality | Vaccine | “novel vaccine candidate PnuBioVax” PMID 29132988 ↗ Nov 2017 |
| Route | Intramuscular | “Three administrations (by intramuscular injection) given 28 days apart to 9 subjects.” NCT02572635 ↗ |